In order to verify the protective effect of wogonoside against the liver injury in NAFLD mice, the effects of wogonoside on the body mass, liver mass, liver index and AST and ALT activities in the serum of NAFLD mice were detected. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.